WOOJUNG BIO Inc (215380) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.10x

WOOJUNG BIO Inc (215380) has a Cash Flow Reinvestment Rate of 0.10x as of December 2025, reinvesting ₩190.52 Million (capex ₩0.00 plus investments ₩190.52 Million) from operating cash flow of ₩1.91 Billion. See WOOJUNG BIO Inc (215380) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.10x
(Capex + Investments) / Operating CF

Total Reinvested

₩190.52 Million
Capex + Investments

Operating Cash Flow

₩1.91 Billion
KRW

Capital Expenditures

₩0.00
KRW

WOOJUNG BIO Inc Cash Flow Reinvestment Rate (2019–2022)

Historical reinvestment intensity for WOOJUNG BIO Inc across 3 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of WOOJUNG BIO Inc.

Annual Cash Flow Reinvestment Rate for WOOJUNG BIO Inc (2019–2022)

Year-by-year capital reinvestment analysis for WOOJUNG BIO Inc. See 215380 financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2022 6.49x ₩16.25 Billion ₩2.50 Billion ₩11.42 Billion ▼ -74.2%
2021 25.22x ₩43.58 Billion ₩1.73 Billion ₩36.68 Billion ▼ -30.3%
2019 36.16x ₩7.55 Billion ₩208.72 Million ₩2.16 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow